Pancreatic Cancer Research

ResearcherNorth Dakota State UniversityActive in the last 2 years

Megan Orr

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0375-3150; OpenAlex author ID A5075039061; NIH RePORTER profile ID 12271698. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
30
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 grant

Papers 5

  1. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Co-author DOI 10.1371/journal.pone.0289183↗
  2. A Pilot Study of Blood-Based Methylation Markers Associated With Pancreatic Cancer. First author DOI 10.3389/fgene.2022.849839↗
  3. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.0c00499↗
  4. Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways. Co-author DOI 10.3390/cancers12061501↗
  5. Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models. Co-author DOI 10.18632/oncotarget.23623↗

Grants 1

  1. Biostatistics and Bioinformatics Core Facility P20GM109024↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Katie M. Reindl · 3 shared papers, 1 shared grant, 2018–2026 · strength 0.82
  2. Sanku Mallik · 2 shared papers, 1 shared grant, 2021–2026 · strength 0.75
  3. Rick J. Jansen · 1 shared paper, 1 shared grant, 2022–2026 · strength 0.69
  4. Mohiuddin Quadir · 1 shared paper, 1 shared grant, 2021–2026 · strength 0.57
  5. John Curlee Wilkinson · 1 shared paper, 1 shared grant, 2018–2026 · strength 0.54
  6. Sathish Venkatachalem · 1 shared grant, 2026 · strength 0.46
  7. Jiha Kim · 1 shared grant, 2026 · strength 0.46
  8. Ang Guo · 1 shared grant, 2026 · strength 0.46
  9. Mark T Hamann · 1 shared grant, 2026 · strength 0.46
  10. Roberto Gomes · 1 shared grant, 2026 · strength 0.46
  11. Jagdish Singh · 1 shared grant, 2026 · strength 0.46
  12. Estelle Leclerc · 1 shared grant, 2026 · strength 0.46
  13. Elisabetta Liverani · 1 shared grant, 2026 · strength 0.46
  14. Erxi Wu · 1 shared grant, 2026 · strength 0.46
  15. Bin Guo · 1 shared grant, 2026 · strength 0.46
  16. Yongki Choi · 1 shared grant, 2026 · strength 0.46
  17. Guodong Liu · 1 shared grant, 2026 · strength 0.46
  18. Buddhadev Layek · 1 shared grant, 2026 · strength 0.46
  19. Jiyan Mohammad · 2 shared papers, 2018–2020 · strength 0.24
  20. Gloria M. Petersen · 1 shared paper, 2022 · strength 0.22
  21. Kaitlin M. Dailey · 1 shared paper, 2023 · strength 0.18
  22. Amanda E. Brooks · 1 shared paper, 2023 · strength 0.18
  23. Michael Anthony Hollingsworth · 1 shared paper, 2023 · strength 0.18
  24. Rahul Raj Singh · 1 shared paper, 2020 · strength 0.16
  25. Gauthami Nair · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.